PROCEPT BioRobotics Corp (PRCT): Cost of Revenue

Annual figures by period end, from SEC filings.

$111.83M
Year ended 2025-12-31
$120.69M
Trailing 12 months to 2026-06-30
+43.4%
3-year compound annual growth
+65.6%
5-year compound annual growth
2020-12-31: $8.97M2021-12-31: $18.61M2022-12-31: $37.93M2023-12-31: $65.14M2024-12-31: $87.40M2025-12-31: $111.83M$111.83M
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$111.83M+28.0%2026-02-26, From 2025-01-01
2024-12-31$87.40M+34.2%2026-02-26, From 2024-01-01
2023-12-31$65.14M+71.7%2026-02-26, From 2023-01-01
2022-12-31$37.93M+103.8%2025-02-27, From 2022-01-01
2021-12-31$18.61M+107.4%2024-02-28, From 2021-01-01
2020-12-31$8.97Mn/a2022-03-22, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
PROCEPT BioRobotics Corp (PRCT)2025-12-31$111.83M+28.0%
SkinHealth Systems Inc. (SKIN)2025-12-31$104.43M-31.3%
Angiodynamics Inc (ANGO)2026-05-31$145.28M+7.8%
Tactile Systems Technology Inc (TCMD)2025-12-31$79.38M+4.0%
Lemaitre Vascular Inc (LMAT)2025-12-31$71.06M+3.0%
Orthopediatrics Corp (KIDS)2025-12-31$63.69M+13.5%
Accuray Inc (ARAY)2026-06-30$290.49M-6.8%
Mimedx Group, Inc. (MDXG)2025-12-31$73.01M+21.5%
Artivion, Inc. (AORT)2025-12-31$157.10M+12.4%

Compare PRCT, SKIN, ANGO, TCMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗